韦氏病毒是与肠道相关的噬菌体,可感染克雷伯氏菌属。

Weberviruses are gut-associated phages that infect Klebsiella spp.

作者信息

Dawson Samuel J T, Shibu Preetha, Garnett Sara, Newberry Fiona, Brook Thomas C, Tijani Tobi, Kujawska Magdalena, Hall Lindsay J, McCartney Anne L, Negus David, Hoyles Lesley

机构信息

Department of Biosciences, Nottingham Trent University, Nottingham, NG11 8NS, United Kingdom.

Life Sciences, University of Westminster, London, W1W 6UW, United Kingdom.

出版信息

FEMS Microbiol Ecol. 2025 Apr 14;101(5). doi: 10.1093/femsec/fiaf043.

Abstract

Weberviruses are bacteriophages (phages) that can infect and lyse clinically relevant, multidrug-resistant (MDR) strains of Klebsiella. They are an attractive therapeutic option to tackle Klebsiella infections due to their high burst sizes, long shelf life, and associated depolymerases. In this study, we isolated and characterized seven new lytic phages and compared their genomes with those of their closest relatives. Gene-sharing network, ViPTree proteome, and terL gene-sequence-based analyses incorporating all publicly available webervirus genomes [n = 258 from isolates, n = 65 from metagenome-assembled genome (MAG) datasets] confirmed the seven phages as members of the genus Webervirus and identified a novel genus (Defiantjazzvirus) within the family Drexlerviridae. Using our curated database of 265 isolated phage genomes and 65 MAGs (n = 330 total), we found that weberviruses are distributed globally and primarily associated with samples originating from the gut: sewage (154/330, 47%), wastewater (83/330, 25%), and human faeces (66/330, 20%). We identified three distinct clusters of potential depolymerases encoded within the 330 genomes. Due to their global distribution, frequency of isolation and lytic activity against the MDR clinical Klebsiella strains used in this study, we conclude that weberviruses and their depolymerases show promise for development as therapeutic agents against Klebsiella spp.

摘要

韦氏病毒是一种噬菌体,能够感染并裂解临床上具有重要意义的多重耐药性(MDR)克雷伯氏菌菌株。由于其高爆发量、长保质期以及相关的解聚酶,它们是应对克雷伯氏菌感染的一种有吸引力的治疗选择。在本研究中,我们分离并鉴定了七种新的裂解性噬菌体,并将它们的基因组与其最接近的亲缘噬菌体进行了比较。基因共享网络、ViPTree蛋白质组以及基于terL基因序列的分析纳入了所有公开可用的韦氏病毒基因组(来自分离株的n = 258个,来自宏基因组组装基因组(MAG)数据集的n = 65个),证实这七种噬菌体为韦氏病毒属的成员,并在德雷克斯勒病毒科内鉴定出一个新属(挑衅爵士病毒属)。使用我们精心策划的包含265个分离噬菌体基因组和65个MAG(共n = 330个)的数据库,我们发现韦氏病毒在全球分布,并且主要与源自肠道的样本相关:污水(154/330,47%)、废水(83/330,25%)和人类粪便(66/330,20%)。我们在330个基因组中鉴定出了三个不同的潜在解聚酶簇。由于它们的全球分布、分离频率以及对本研究中使用的多重耐药临床克雷伯氏菌菌株的裂解活性,我们得出结论,韦氏病毒及其解聚酶有望开发成为针对克雷伯氏菌属的治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/294c/12023860/5b7fe8a93e3b/fiaf043fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索